SCHEMBL8103281

SCHEMBL8103281

Cc1ccc(-c2cnc3cc4[nH]ncc4cc3n2)c(C)c1.Cc1ccc(-c2cnc3cc4cn[nH]c4cc3n2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FGFR1 P11362 2/20 0.45
▸ MAPK1 P28482 2/20 0.44
▸ FLT3 P36888 2/20 0.43
▸ NPC1 O15118 2/20 0.43
▸ KDR P35968 2/20 0.43
▸ PDGFRB P09619 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ TRPA1 O75762 2/20 0.42
▸ ROCK2 O75116 4/20 0.40
▸ GSK3B P49841 3/20 0.40
▸ ROCK1 Q13464 2/20 0.40
▸ AURKA O14965 1/20 0.40
▸ PRKCG P05129 1/20 0.40
▸ CDK1 P06493 1/20 0.40
▸ PRKACA P17612 1/20 0.40
▸ RPS6KB1 P23443 1/20 0.40
▸ CDK2 P24941 1/20 0.40
▸ GSK3A P49840 1/20 0.40
▸ PRKAA1 Q13131 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6617397 0.94 FGFR1 (0.44) FGFR1MAPK1FLT3NPC1KDR
SCHEMBL6618800 0.94 FGFR1 (0.44) FGFR1MAPK1FLT3NPC1KDR
SCHEMBL6621230 0.90 MAPK1 (0.49) FGFR1MAPK1FLT3NPC1KDR
SCHEMBL6618612 0.90 MAPK1 (0.49) FGFR1MAPK1FLT3NPC1KDR
SCHEMBL6618925 0.80 TRPA1 (0.55) FGFR1MAPK1FLT3NPC1KDR
SCHEMBL6616566 0.80 NPC1 (0.57) FGFR1MAPK1FLT3NPC1KDR
SCHEMBL6621847 0.80 TRPA1 (0.55) FGFR1MAPK1FLT3NPC1KDR
SCHEMBL8110919 0.80 TRPA1 (0.55) FGFR1MAPK1FLT3NPC1KDR
SCHEMBL6617887 0.80 NPC1 (0.57) FGFR1MAPK1FLT3NPC1KDR
SCHEMBL6619870 0.79 BCHE (0.54) FGFR1MAPK1FLT3NPC1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0779889-A4 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE POULENC RORER PHARMA (US) 2000-02-23 — — EP disclosed
EP-0779889-A1 PYRAZOLO 3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1997-06-25 — — EP disclosed
WO-1996007658-A1 PYRAZOLO[3,4-g]QUINOXALINE COMPOUNDS WHICH INHIBIT PDGF RECEPTOR PROTEIN TYROSINE KINASE RHONE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-03-14 — — WO disclosed
Send feedback